FDA Approves Implantable Glucose Monitor That Lasts For 90 Days

News Senseonics Holdings, Inc. announced the U.S. Food and Drug Administration has approved its Pre-market Approval application to market the company's Eversense Continuous Glucose Monitoring System to people with diabetes in the United States... Contributed Author: Senseonics Holdings Topics: Diabetes